Current Evidence of Maternal Infection With Chlamydia trachomatis and Preeclampsia Risk

Area of Science:

• Reproductive Health
• Infectious Diseases
• Maternal-Fetal Medicine

Background:

• Chlamydia trachomatis is the most common bacterial sexually transmitted infection (STI) in the United States.
• Ascending C. trachomatis infections can lead to pelvic inflammatory disease (PID), infertility, ectopic pregnancy, and adverse pregnancy outcomes.
• Infections are increasingly implicated in preeclampsia, a serious maternal hypertensive disorder, but the role of STIs remains understudied.

Purpose of the Study:

• To review the potential association between Chlamydia trachomatis and preeclampsia.
• To identify future research needs by critically evaluating existing evidence.
• To explore potential biological mechanisms linking C. trachomatis to preeclampsia.

Main Methods:

• Review of epidemiologic, in vitro, and in vivo studies.
• Critical evaluation of current research methodologies and limitations.
• Assessment of bench-side approaches, including animal models and in vitro studies.

Main Results:

• Methodological limitations (study design, bias, diagnostic variations) hinder understanding of C. trachomatis' impact on preeclampsia.
• Current in vitro and animal studies have not clarified the specific mechanisms linking C. trachomatis to preeclampsia.
• A clear association and underlying biological pathways remain to be fully elucidated.

Conclusions:

• Further high-quality research is essential to confirm or refute the association between C. trachomatis and preeclampsia.
• Elucidating the biological pathways disrupted by chlamydia is crucial for developing novel therapeutics.
• Understanding this link may guide the development of treatments to reduce preeclampsia pathology beyond standard antibiotic therapy.